- Home
- RF vs BNTX Comparison
RF vs BNTX Comparison
Compare RF & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RF | BNTX |
|---|---|---|
| Founded | 1970 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3B | 24.2B |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RF | BNTX |
|---|---|---|
| Price | $30.42 | $103.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 13 |
| Target Price | $29.44 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 6.7M | 1.5M |
| Earning Date | 04-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.78% | N/A |
| EPS Growth | ★ 19.17 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $104,000,000.00 | N/A |
| Revenue This Year | $14.98 | N/A |
| Revenue Next Year | $3.82 | $3.37 |
| P/E Ratio | $24.14 | ★ N/A |
| Revenue Growth | ★ 23.81 | N/A |
| 52 Week Low | $22.70 | $79.81 |
| 52 Week High | $32.47 | $124.00 |
Technical Indicators
Market Signals| Indicator | RF | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 52.93 |
| Support Level | $29.83 | $87.58 |
| Resistance Level | $31.97 | $104.05 |
| Average True Range (ATR) | 0.56 | 4.11 |
| MACD | -0.13 | -0.76 |
| Stochastic Oscillator | 40.80 | 41.22 |
Price Performance
Historical ComparisonAbout RF Regions Financial Corporation
Regions Financial is one of the midsized regional banks in the US, with around $160 billion in total assets as of the end of first quarter of 2026. Headquartered in Birmingham, Alabama, Regions Financial has a footprint mostly in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, wealth management, and capital markets.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.